{"name":"David M. Brown, M.D.","slug":"david-m-brown-m-d","ticker":"","exchange":"","domain":"","description":"David M. Brown, M.D. is a specialized pharmaceutical company focused on the development and commercialization of ophthalmic treatments. The company has two drugs in its pipeline, including a marketed product and an early-stage candidate.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPUVpVZHZvVDZKVjVvVDB0NU9pTXFRd3Z1WnNWbllZOVNmR29Zcnk3VFFrVUhlaWhuS2FKSm5TVXZjNnliOU9ydDVMWFg3bk9zbzB0RG9fb2RpXzNNSEFaN3pZekV2Ul9INmktSVhWZUFtNDg4bEdtcmRWY0hOWGZLMEE1bEFfQkd2SzIxX3hPS3R5Y2dVSExsN295UWU5MmY1UUFYMTZR?oc=5","date":"2026-02-05","type":"pipeline","source":"HCPLive","summary":"Targeting Costimulatory Pathways in Kidney Transplant With Eliezer Katz, MD - HCPLive","headline":"Targeting Costimulatory Pathways in Kidney Transplant With Eliezer Katz, MD","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNWXNCTmQtOTk3MFZ6LXNkb1hfeUdaeHdyYjkzYWtOZUZtZXEzZkxTR2hOUDRJUWk3VWI2bnNJZE1sWVdteGFzWVRfV0dpQm5YbFVhRmVVa0dLSWExaHJvM2VMbEpMT3g5NW1XLWhWN3FCLU81Vlk1UmZFS2E0bFVBR3lyQlp3NVZJRzl0MDdYcXpCYUwwQnlpOWVaSGNPall2bVJrdVhWWUVkZDRMdmxJOWROSHM?oc=5","date":"2025-12-02","type":"regulatory","source":"Ophthalmology Times","summary":"FDA approves Amneal Pharmaceuticals' cyclosporine ophthalmic emulsion 0.05% - Ophthalmology Times","headline":"FDA approves Amneal Pharmaceuticals' cyclosporine ophthalmic emulsion 0.05%","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxQWlZyNVBCOU92Q0Jia3dmNmg5OWMtWDdFNUdnN3psNWFNeE9fU3MxUnVmNmNHNURDOVQyYUh6VFhzY09ncmpHbDBWczNscU9PQkFOcm5xcWZuT2dVNnJLQS1ZRmVraTJNZGhMeGFaUllfUENMUEFpeWNaTXRfT2E1NU9FY1ZlYmUtUWl0MjFNWGVEMXRvdmxUUVhXbGhrcEVUbEtWX0U0OWpPb2h1Q3VRejhR?oc=5","date":"2025-10-28","type":"pipeline","source":"Ophthalmology Times","summary":"Bimatoprost drug pad-IOL system shows reduction in mean IOP at 24 months - Ophthalmology Times","headline":"Bimatoprost drug pad-IOL system shows reduction in mean IOP at 24 months","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE1rRGlhcS1WQkc0dHJndlg2SS1mS1ctbkRSQ2J0eGZ5dUpwT0RCaElrdUkxZDdtNE9pSTVpcUUtWTN2d0l5cUVrMDJlTnNtbVNEdjFpbzJhNzVPNTZlSE5FR2wwOXhqTDhmMDQ0aS1RWWcyYV94WUE?oc=5","date":"2025-09-10","type":"regulatory","source":"Psychiatry Online","summary":"Real-World Safety of Esketamine Nasal Spray: A Comprehensive Analysis Almost 5 Years After First Approval - Psychiatry Online","headline":"Real-World Safety of Esketamine Nasal Spray: A Comprehensive Analysis Almost 5 Years After First Approval","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxPM1R6UnBNemotSkp3Vld6em1XdU40U2FFamZWeXRWSGxHMUljazZ5eEVudGd6VjdTd3hrMkxfel9IcWtVZW54a0VqbURNMEJlRG9wNXRjMEl5aEZCWFJvOHdkWUtFR1I2cWxfUV9kbW9OMTMyQnBLeXFMN1BpQW5mVVAtWVVCbktsRGtIeXAtTjVfTC1UUTAxcnQwbWNMMXM?oc=5","date":"2025-05-29","type":"pipeline","source":"Modern Retina","summary":"David Tanzer, MD, CMO of Lexitas reflects on Retina World Congress - Modern Retina","headline":"David Tanzer, MD, CMO of Lexitas reflects on Retina World Congress","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxOS29uTVFXdHpudkFQWEZHLVBpU2NuVmFabGgwazdIaE1JYjFoZUtSWWxmUGZXUE8xT3kxOEM3aG1kQmpQQWFRbzgxMng0bkY0UlNSNEdWM3NoeTdUZWlkUkI3WFV6bk13anFnWER0NE83R2tmTk81VXh6TXExaVpDSS00dXpMNV9CZ1NJZVd4eVp6eUZzT3N5c2VHRmxuUklaSFNCRE9Penh4N25rMDdUVFFYTEhPR2JVQWo2cDI0cG0tUzg?oc=5","date":"2024-10-09","type":"pipeline","source":"Fierce Pharma","summary":"Clearside eye disease candidate aces exam in pursuit of Roche's Vabysmo and Regeneron, Bayer's Eylea - Fierce Pharma","headline":"Clearside eye disease candidate aces exam in pursuit of Roche's Vabysmo and Regeneron, Bayer's Eylea","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQUWM1Ym1YQ0M5TVNRVEtVcDhvRi1DY3VXU0VHUVJxclZLY19WWVItN2ZBY2Q3ZElOZ3RRMDZYTFNPZXliY0xSanNjY3lUcldxZTYxbWNXZk0zWkxSXzY1RVpiYklpRlJIMll6LVA5ZTQ3b3R1d1c5RXkyZDc0Z2FnNmNCTlZiUTRYUjhn?oc=5","date":"2024-03-07","type":"regulatory","source":"The Lancet","summary":"Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial - The Lancet","headline":"Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwJBVV95cUxOeDM4NUhIcWJUWTBPNW1ZUnRRcW0xUEZLOFE1RU5oMjVIS2gtbnEzY1lTMzFiMEJ6d1VfNEVNUlFKZFJaeGYxMXpvNkQybk5wZU95dms5RXM5dHgtMTlRWVlzZWdQd2MwS0lZU2ZpVmRsdFp4a2JNSmhPWWMxa3lVUHpGRFpSQ1hTcnZSbVAxa3h0WERLVU91WEJPbnhJR29UaUw1c1Jnd1IxV3ZUbDQ1TG1VUFFKajhTRHBQZ2lSdVdtRDlhU0kyd0FoSlk3SmZzWjgtNDlkUXVMN1A4M0ZYcVlJNFV2MExoVVc0VkxOTDZRcGtWMXRmRjh3VTktbzRfbUkxSEtHUnQ2VFl3Y20yaFVhcXBNdFZaWXFpU3ZRZ1E0SlM2bTd4WHR3TQ?oc=5","date":"2023-10-19","type":"pipeline","source":"The University of Maryland, Baltimore","summary":"2020 Archive - The University of Maryland, Baltimore","headline":"2020 Archive - The University of Maryland, Baltimore","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxQQUI0ZE9QbWZmNmt4U2FTT0ZtNW5LcnRUYnFKVi1pNjVXVkxRVDVrYUViOG5YQnZvLVREcWJxQTQ1VTdMMEpjMHVpc2M1ZW5IV3dMeDQtOTJuekJaQzA5Yk1TZmo4M2tDUmc1Q0Y5MmFmSXpJTFE2Rm5Nb3JHcld1dWoxZmFDNk0?oc=5","date":"2023-06-28","type":"regulatory","source":"managedhealthcareexecutive.com","summary":"FDA Rejects Higher Dose of Eylea - managedhealthcareexecutive.com","headline":"FDA Rejects Higher Dose of Eylea","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxQZ0xaOUx1X2I4OEh2M1FaRU0zbVI3N3NYYjhWRDNEQ29XNXpQeHlWalJUck1KVEtVU2pocW5mNTU3aGgzSmpoSllUNUhoRUVXUEJicjFDYld4ZVZENGNvN2o2SUJlVFhDZThCOTAyQlk0QjVxN3R0dFhPQ3FFZF9wWEgzZzF5UDE2NW9KWnJfM1dPRUhWel80LWxTMDY?oc=5","date":"2023-03-17","type":"earnings","source":"Campden FB","summary":"Dr. David Brown: How Viagra opened the doors to machine learning innovation - Campden FB","headline":"Dr. David Brown: How Viagra opened the doors to machine learning innovation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTE9wOTNlb3ZyNjl1OU1HMFo2bGJ1OU9jaDV4UEtLX05sYjhxTHJNRG01UmtpUXJhR2phRURLUFRfN1ZBTU9CbjRkV2tCaXE3cXppUGJGdWhjU1BiY25WNnM2SQ?oc=5","date":"2018-05-20","type":"pipeline","source":"NEJM","summary":"Procalcitonin-Guided Use of Antibiotics for Lower Respiratory Tract Infection - NEJM","headline":"Procalcitonin-Guided Use of Antibiotics for Lower Respiratory Tract Infection","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxQVDVOb3ZVV2x5T0FMdEladHg2OUVHTzRvVW5vT09MeFZGRWQ5aVA2cHI3V0RJSEZaVG9XdFk5QjVwcDZleklzcnllRF9Hc09WSHhTM2dydnlUOXVlaUFhMWpUVHJENy1SaVFOZVlIY1lKMmQtX2Q2UlplZ203ZXhJaXlzT0syT2dkdHVxYWpuTUgyd05tdXN3OGt5cnI1NjhseWc?oc=5","date":"2015-11-29","type":"pipeline","source":"The Star Press","summary":"Doctor disciplined in pain killer OD - The Star Press","headline":"Doctor disciplined in pain killer OD","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}